The GLP-1 receptor agonist market features a variety of approved and investigational products, including short-acting agonists like exenatide and lixisenatide, long-acting options such as semaglutide, dulaglutide, and liraglutide, as well as oral formulations like oral semaglutide (Rybelsus)
Nurses play an equally important role in encouraging patients to share this information with external providers and their primary pharmacy to ensure the entire healthcare team remains well-informed
doi: 10.3109/01485019008987590 52 KrassasGEPapadopoulouFTziomalosKZeginiadouTPontikidesN
Complete the Vitamin Intake Form on our Start Now page to get started
[DOI] [PubMed] [Google Scholar] 216.Hotta K, Funahashi T, Arita Y, et al
This personalization helps ensure your GLP-1 remains therapeutically active throughout your treatment period